Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8731692 | 1.00 | CA1 (0.52) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL7784650 | 1.00 | CA1 (0.52) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL30580551 | 0.97 | CA1 (0.50) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL4347545 | 0.97 | CA1 (0.50) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL29594997 | 0.97 | CA1 (0.50) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL6343379 | 0.97 | CA1 (0.50) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL3294626 | 0.97 | CA1 (0.50) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL11564367 | 0.97 | CA1 (0.50) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL6343377 | 0.97 | CA1 (0.50) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL4347547 | 0.97 | CA1 (0.50) | CA1CA9ALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4536292-A1 | MITOCHONDRIA AS A TARGETED DELIVERY PLATFORM | cellvie AG (CH) | 2025-04-16 | — | — | EP | claimed |
| CN-118638305-A | Polybutylene carbonate ionic polymer, suspension auxiliary agent containing polybutylene carbonate ionic polymer, grinding fluid containing polybutylene carbonate ionic polymer, preparation method and application of polybutylene carbonate ionic polymer | 浙江奥首材料科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| WO-2023237788-A1 | MITOCHONDRIA AS A TARGETED DELIVERY PLATFORM | CELLVIE AG (CH) | 2023-12-14 | — | — | WO | claimed |
| US-5439688-A | Process for preparing a pharmaceutical composition | DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) | 1995-08-08 | — | — | US | claimed |
| US-12570796-B2 | Polyester polymer nanocomposites | KINTRA FIBERS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-20250380688-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION AND CONTROL METHOD USING THE SAME | SHINETSU CHEMICAL CO (JP) | 2025-12-18 | — | — | US | disclosed |
| US-20250333596-A1 | POLYESTER POLYMER NANOCOMPOSITES | KINTRA FIBERS INC (US) | 2025-10-30 | — | — | US | disclosed |
| CN-119955287-A | Polyphenyl ether/polyamide alloy and preparation method and application thereof | 金发科技股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-4536292-A1 | MITOCHONDRIA AS A TARGETED DELIVERY PLATFORM | cellvie AG (CH) | 2025-04-16 | — | — | EP | disclosed |
| CN-119486767-A | Mitochondria as targeted delivery platform | 赛尔维股份公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20250034330-A1 | POLYESTER POLYMER NANOCOMPOSITES | KINTRA FIBERS, INC. | 2025-01-30 | — | — | US | disclosed |
| US-12202967-B2 | Polyester polymer nanocomposites | KINTRA FIBERS, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| EP-1469869-A2 | PEPTIDE USEFUL IN IMMUNOMODULATION | Cure Tech Ltd. (IL) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003033644-A2 | PEPTIDE USEFUL IN IMMUNOMODULATION | CURE TECH LTD. (IL) | 2003-04-24 | — | — | WO | disclosed |
| WO-2002005806-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CAPSAICIN FOR THE TREATMENT OF PRURITUS ANI | HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. (IL) | 2002-01-24 | — | — | WO | disclosed |
| EP-1088843-A3 | Nonlinear crystalline polyester | KAO CORPORATION (JP) | 2001-10-17 | — | — | EP | disclosed |
| EP-1087783-A2 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF $i(HELICOBACTER PYLORI)-ASSOCIATED DISORDERS | Chowers, Michal Y. (IL) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999065513-A2 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI-ASSOCIATED DISORDERS | CHOWERS MICHAL Y (IL) | 1999-12-23 | — | — | WO | disclosed |
| US-4146417-A | Method for producing bonded nonwoven fabrics using ionizing radiation | JOHNSON & JOHNSON (US) | 1979-03-27 | — | — | US | disclosed |
| US-4091140-A | Continuous filament nonwoven fabric and method of manufacturing the same | JOHNSON & JOHNSON (US) | 1978-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250380688-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION AND CONTROL METHOD USING THE SAME | GNRHR, GHRHR, SHBG | CA1 117/4885CA9 198/4885ALDH1A1 2877/4885 |
| US-12570796-B2 | Polyester polymer nanocomposites | SORD, BECN1, DSP | CA1 430/4885CA9 605/4885ALDH1A1 879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.